AZD0914

• Healthcare
• Pharma & Biotech
• Technology
• United Kingdom

AstraZeneca’s novel antibiotic candidate AZD0914 designated as Qualified Infectious Disease Product and awarded Fast Track status by US FDA

London, UK, 03-6-2014 — /EuropaWire/ — AstraZeneca today announced that the US Food and Drug Administration (FDA) has designated its novel investigational…